Journal
CURRENT OPINION IN CHEMICAL BIOLOGY
Volume 15, Issue 4, Pages 570-575Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.cbpa.2011.06.016
Keywords
-
Categories
Ask authors/readers for more resources
Drug target deconvolution is a process where the action of a drug, a small molecule, is characterised by identifying the proteins binding the drug and initiating the biological effect. The biological relevant target has to be extracted, or deconvoluted, from a list of proteins identified in such an approach. Beside the medically desired action of the drug, the identification of other proteins binding the drug can help to identify side effects and toxicity at a very early stage of drug development. The current approach to identify the proteins binding to the drug is an affinity-enrichment based approach, where the drug molecule is immobilised to a matrix through a linker and the proteins binding to the drug are identified by proteomics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available